myirislogo
15 August, 2018 17:08 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Stl 578.90 1.70
Sun Pharma 601.65 6.91
State Bank O 294.70 0.03
I T C 307.25 0.44
Icici Bank 332.30 2.17
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Dr Reddy`S Laboratories Limited
Dr Reddy`S Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:500124NSE:DRREDDYBloomberg:DRRD@INReuters:REDY.BO
Market Lot: 1Face Value: 5ISIN Demat: INE089A01023
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
26-JUL-18 Dr. Reddy's Laboratories announced today that it has launched Hervycta (Trastuzumab ), a biosimilar of Roche's Herceptin in India, indicated for the treatment of HER2-positive cancers (early breast cancer, metastatic breast cancer and metastatic gastric cancer). 16-JUL-18 Dr. Reddy's Laboratories, today announced its intent to appeal the decision made by the U.S. District Court for the District of New Jersey in a preliminary injuncti...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Dr. Reddy's Lab launches of Hervycta in India  -IRIS 26-Jul-18
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Dec-2016(9)31-Mar-2016(12)31-Mar-2015 (12)
Net sales 73286.00101284.6099274.50
Other Income5447.003070.902228.50
Total Income78733.00104355.50101503.00
Cost of goods sold62872.0078660.2076199.40
OPBDIT15861.0025695.3025303.60
PAT11611.0013544.7016793.50
Gross Block---
Equity capital829.00853.00851.90
EPS (Rs.)--98.60
DPS (Rs.)---
BV (Rs.)---
P/E range (x)--22.82 - 37.14
Debt / Equity (x)---
Operating margin (% of OI)20.124.624.9
Net margin (% of OI)14.713.016.5
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
8-2-337, Road No. 3
Banjara Hills
Hyderabad
Andhra Pradesh-500 034
PHONE
- - -
FAX
- - -
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer